A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease.
Clinical trial NCT06675175 · COMPLETED
Trial details
- NCT number
- NCT06675175
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2025-10-27
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.